Not applicableUnknownNCT03131232
What this trial is testing
The Effect of Empagliflozin on Glucose Metabolism, Weight, Blood Pressure and Cardiac Function (NT-proBNP) Should be Investigated
Who this might be right for
Diabetes Mellitus, Type 2
RWTH Aachen University 46